The therapeutic drug monitoring market is projected to reach USD 2.55 Billion by 2020 from USD 1.78 billion in 2015, growing at a CAGR of 7.4% during the forecast period (2015–2020). In this report, the therapeutic drug monitoring market is broadly segmented by product, technology, class of drug, end user, and region.
Complete report of 80 market data Tables with 55 Figures across 142 Pages and in-depth TOC on “Therapeutic Drug Monitoring Market" @ http://www.rnrmarketresearch.com/therapeutic-drug-monitoring-market-by-product-consumables-equipment-technology-immunoassays-proteomic-technologies-class-of-drug-antiepileptics-antibiotics-immunosuppressants-end-user-hospital-labs-pr-st-to-2020-market-report.html .
North America is expected to account for more than half the therapeutic drug monitoring market share in 2015. It is the prime market for therapeutic drug monitoring due to the high awareness and acceptance of the benefits of therapeutic drug monitoring and growing healthcare expenditure. Europe on the other hand is growing at a slower rate as the healthcare sector is recovering from the economic downturn and healthcare facilities are trying to minimize healthcare delivery costs.
Growth in the APAC therapeutic drug monitoring market is comparatively slower due to the dearth of skilled healthcare personnel who can perform therapeutic drug monitoring tests with minimal errors. Focus on cost effectiveness of therapeutic drug monitoring and increase in R&D investments will boost the growth of therapeutic drug monitoring market
The competitive landscape covers the various strategies adopted by industry players to maintain their position in the therapeutic drug monitoring market. The company profiles comprise the basic views on the key players in the therapeutic drug monitoring market and the product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares.
Click here for more information on this research at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=518398 .
From an insight perspective, this research report focuses on the qualitative data, future market size, share, and market potential of various segments and subsegments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis such as market dynamics (drivers, restraints, opportunities, and challenges) and technological trends in therapeutic drug monitoring. It mainly focuses on the emerging and high-growth segments of the therapeutic drug monitoring market and government initiatives across regions.
Major players in the therapeutic drug monitoring market include F. Hoffmann-La Roche AG (Switzerland), Siemens Healthcare (Germany), Thermo Fisher Scientific (U.S.), Bio-Rad Laboratories Inc. (U.S.), and Danaher Corporation (U.S.).
Single user PDF, a order copy of “Therapeutic Drug Monitoring Market by Product (Consumables, Equipment), Technology (Immunoassays, Proteomic Technologies), Class of Drug (Antiepileptics, Antibiotics, Immunosuppressants), End User (Hospital Labs, Private Labs) - Global Forecast to 2020” research report at http://www.rnrmarketresearch.com/contacts/purchase?rname=518398 .
Research hightlights the topics
This research report has focused on various levels of analysis—industry analysis (industry trends), market share analysis of top players and company profiles, which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth market segments; high-growth regions; and market drivers, restraints, and opportunities.
Explore more reports on Medical Devices at http://www.rnrmarketresearch.com/reports/life-sciences/medical-devices .
RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets.
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013